DNA Script Stock
DNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology.
About DNA Script Stock
DNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology. The company aims at accelerating innovation in life science and technology through rapid, affordable and high quality DNA synthesis. It has the potential to greatly accelerate the development of new therapeutics, sustainable chemical production, improved crops as well as new applications such as data storage.
Funding History
| August 2015 | $0 |
|---|---|
| June 2016 | $2.5M |
| September 2017 | $11.0M |
| April 2018 | $5.5M |
| July 2018 | $2.7M |
Management
Co-founder & CEO
Thomas Ybert
Co-founder & COO
Sylvain Gariel
Co-founder & CTO
Xavier Godron
Press
DNA Script picks up $38.5 million to make DNA production faster and simpler
TechCrunch - May, 17 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from DNA Script or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
